Lynx Investment Advisory’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$300K Sell
1,227
-22
-2% -$5.12K 0.14% 140
2025
Q4
$258K Sell
1,249
-3
-0.2% -$593 0.14% 146
2025
Q3
$232K Buy
+1,252
New +$215K 0.14% 141
2025
Q2
Sell
-2,213
Closed -$367K 151
2025
Q1
$367K Buy
2,213
+125
+6% +$19.6K 0.24% 84
2024
Q4
$302K Buy
2,088
+229
+12% +$35.5K 0.21% 111
2024
Q3
$301K Buy
1,859
+423
+29% +$67.4K 0.22% 105
2024
Q2
$210K Buy
+1,436
New +$214K 0.16% 125

Other funds holding JNJ

Lynx Investment Advisory's JNJ Position: Q1 2026 in Review

Lynx Investment Advisory reduced its Johnson & Johnson (JNJ) stake by 1.8% in Q1 2026, selling an estimated $5.12K and leaving 1,227 shares worth $300K. The position accounts for 0.14% of the portfolio, ranked #140.

Lynx Investment Advisory first reported a position in JNJ in Q2 2024 and has held it in 7 quarters since. The position peaked at $367K in Q1 2025. 4,613 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Lynx Investment Advisory held 1,227 shares of Johnson & Johnson worth $300K as of Q1 2026.
  • Lynx Investment Advisory sold 22 Johnson & Johnson shares in Q1 2026, an estimated $5.12K.
  • Johnson & Johnson made up 0.14% of Lynx Investment Advisory's portfolio in Q1 2026, its #140 holding.
  • Lynx Investment Advisory first reported a position in Johnson & Johnson in Q2 2024 and has held it in 7 quarters since.
  • Lynx Investment Advisory's Johnson & Johnson position peaked at $367K in Q1 2025.
  • 4,613 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Lynx Investment Advisory's 13F filing for Q1 2026, filed 24 Apr 2026.